Skip to content
Agree.net – Lifestyle
Author:
Insilico Medicine
Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women’s Health
March 24, 2026
Insilico Medicine Launches PandaClaw: Empowering Biologists with Agentic AI for Therapeutic Discovery
March 23, 2026
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
March 13, 2026
Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial
March 7, 2026
←
Previous Page
1
2